EUVIMEDAtrasti EUVIMED
Crossref

Recurrence of Primary Sclerosing Cholangitis and De Novo Cholangiocarcinoma After Liver Transplantation: Results From the Brazilian Cholestasis Consortium

Paulo Lisboa Bittencourt, Mateus Jorge Nardelli, Luísa Leite Barros, Guilherme Grossi Lopes Cançado, Eduardo Luiz Rachid Cançado, Débora Raquel Benedita Terrabuio, Cristiane Alves Villela-Nogueira, Maria Lucia Gomes Ferraz, Liana Codes iD, Vivian Rotman, Rodrigo Rocco, Guilherme Eduardo Felga and 13 more

Clinical Transplantation · 2024

DOI: 10.1111/ctr.70002 ↗

At a glance

Journal article in Clinical Transplantation, 2024. Written by Paulo Lisboa Bittencourt and 24 co-authors. Institution: Hospital Português, Salvador, Brazil. Major MEDLINE topics: Cholangitis, Sclerosing, Liver Transplantation, Cholangiocarcinoma, Bile Duct Neoplasms. Cited 8 times so far (Crossref); 42 references. Funded by: Brazilian Society of Hepatology and Instituto Brasileiro do Fígado - IBRAFIG.

SantraukaSubjectsBibliografiniai duomenysCiteRelated studies

Abstract (original language)

Background and Aim Primary sclerosing cholangitis (PSC) has been shown to recur after liver transplantation (LT). Some studies have identified certain clinical and laboratory variables associated with an increased risk for recurrent PSC (rPSC) in Caucasians. Furthermore, de novo cholangiocarcinoma (CCA) has been reported anecdotally in patients with rPSC. This study aims to assess the prevalence of rPSC, identify its associated risk factors, and investigate the occurrence of de novo CCA in a highly admixed population from Brazil.

Methods

All patients submitted to LT for PSC enrolled in the Brazilian Cholestasis Study Group database were retrospectively reviewed for the occurrence of rPSC and de novo CCA.

Results

Ninety‐six (58 males, mean age 32 ± 13 years) patients with PSC underwent LT. After 90 (39–154) months of follow‐up (FU), rPSC was observed in 29 (30%) subjects. There were no significant associations between rPSC and age, gender, concurrent or de novo inflammatory bowel disease, MELD score at the time of LT or allograft rejection. The only factor associated with an increased risk of disease recurrence was time after LT. Although survival was decreased in patients who developed rPSC, this difference was not significant. Only one female patient developed de novo CCA after rPSC, 11 years after LT.

Conclusions

Recurrent PSC was observed in one‐third of PSC LT patients in Brazil and was associated with longer time after LT. Despite its frequency, rPSC was not associated with a higher risk of graft loss or a significant reduction in posttransplant survival.

Subjects

MeSH terms (MEDLINE)

Cholangitis, SclerosingLiver TransplantationCholangiocarcinomaBile Duct NeoplasmsHumansMaleFemaleAdultRetrospective StudiesFollow-Up StudiesRisk FactorsBrazilPrognosisSurvival RateRecurrencePostoperative ComplicationsMiddle AgedCholestasisGraft SurvivalGraft RejectionYoung Adult

Author keywords

cholangiocarcinomaliver transplantationprimary sclerosing cholangitisrecurrent primary sclerosing cholangitis

Authors and institutions

  • Hospital Português, Salvador, Brazil.
  • Escola Bahiana de Medicina e Saúde Pública, Salvador, Brazil.
  • Hospital das Clínicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
  • Departamento de Gastroenterologia, Universidade de São Paulo, São Paulo, Brazil.
  • Hospital da Polícia Militar de Minas Gerais, Belo Horizonte, Brazil.
  • Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.

ORCID profiles: Liana Codes, Luciana Costa Faria

Funding

  • Brazilian Society of Hepatology and Instituto Brasileiro do Fígado - IBRAFIG

Cite

APA

Bittencourt, P. L., Nardelli, M. J., Barros, L. L., Cançado, G. G. L., Cançado, E. L. R., Terrabuio, D. R. B., Villela-Nogueira, C. A., Ferraz, M. L. G., Codes, L., Rotman, V., Rocco, R., Felga, G. E., Dotta, D. D., Martins, A. S., Mendes, L. S. C., da Silva, M. C., Hyppolito, E. B., Gomide, G. P. M., Signorelli, I. V., …, & Couto, C. A. (2024). Recurrence of Primary Sclerosing Cholangitis and De Novo Cholangiocarcinoma After Liver Transplantation: Results From the Brazilian Cholestasis Consortium. Clinical Transplantation. https://doi.org/10.1111/ctr.70002

Vancouver

Bittencourt PL, Nardelli MJ, Barros LL, Cançado GGL, Cançado ELR, Terrabuio DRB, et al. Recurrence of Primary Sclerosing Cholangitis and De Novo Cholangiocarcinoma After Liver Transplantation: Results From the Brazilian Cholestasis Consortium. Clinical Transplantation. 2024. doi:10.1111/ctr.70002

BibTeX
@article{Bittencourt2024,
  author = {Bittencourt, Paulo Lisboa and Nardelli, Mateus Jorge and Barros, Luísa Leite and Cançado, Guilherme Grossi Lopes and Cançado, Eduardo Luiz Rachid and Terrabuio, Débora Raquel Benedita and Villela-Nogueira, Cristiane Alves and Ferraz, Maria Lucia Gomes and Codes, Liana and Rotman, Vivian and Rocco, Rodrigo and Felga, Guilherme Eduardo and Dotta, Diogo Delgado and Martins, Adrielly de Souza and Mendes, Liliana Sampaio Costa and da Silva, Marlone Cunha and Hyppolito, Elodie Bonfim and Gomide, Geisa Perez Medina and Signorelli, Izabelle Venturini and de Oliveira, Maria Beatriz and Ivantes, Claudia Alexandra Pontes and Chindamo, Maria Chiara and de Almeida E Borges, Valéria Ferreira and Faria, Luciana Costa and Couto, Claudia Alves},
  title = {Recurrence of Primary Sclerosing Cholangitis and De Novo Cholangiocarcinoma After Liver Transplantation: Results From the Brazilian Cholestasis Consortium},
  journal = {Clinical Transplantation},
  year = {2024},
  doi = {10.1111/ctr.70002}
}
Start for free →